Ratings
0
Nobody has rated this yet. Be the first!
Works
4
Dasatinib
Dasatinib
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
_2008-01-04.JPG/500px-Leipzig_SAW_(01)_2008-01-04.jpg)
